Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1130 to 1179 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferation-associated protein 2g4 (cell cycle protein p38-2g4 homolog) (hg4-1). [source:swissprot;acc:q9uq80]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.285\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\multirow{14}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.484\vspace{3pt}}}&\multirow{15}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.675\vspace{3pt}}}&\multirow{14}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02731\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.481\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0273\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal membrane protein pex14 (peroxin-14) (peroxisomal membrane anchor protein pex14) (pts1 receptor docking protein). [source:swissprot;acc:o75381]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02729\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.518\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02724\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.505\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0271\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.868\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.522\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1151\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.552\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02693\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1152\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.939\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02676\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inorganic pyrophosphatase (ec 3.6.1.1) (pyrophosphate phospho- hydrolase) (ppase). [source:swissprot;acc:q15181]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.307\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
230.242\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02646\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inorganic pyrophosphatase 2 isoform 1. [source:refseq;acc:nm\_176869]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aryl-hydrocarbon interacting protein-like 1. [source:swissprot;acc:q9nzn9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ah receptor-interacting protein (aip) (immunophilin homolog ara9) (hbv-x associated protein 2). [source:swissprot;acc:o00170]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.877\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.167\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02641\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proline synthetase co-transcribed bacterial homolog protein. [source:swissprot;acc:o94903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
170.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
165.898\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2-oxoglutarate dehydrogenase e1 component, mitochondrial precursor (ec 1.2.4.2) (alpha-ketoglutarate dehydrogenase). [source:swissprot;acc:q02218]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.041\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02633\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kappa b-ras 1. [source:refseq;acc:nm\_020345]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.758\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.097\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02632\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
i-kappa-b-interacting ras-like protein 2. [source:refseq;acc:nm\_017595]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
snare associated protein snapin. [source:refseq;acc:nm\_012437]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 4. [source:swissprot;acc:q04727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.438\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.818\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02628\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 3 (esg3). [source:swissprot;acc:q04726]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.401\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.785\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02627\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 2 (esg2). [source:swissprot;acc:q04725]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.374\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.759\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein engrailed-2 (hu-en-2). [source:swissprot;acc:p19622]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.399\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.784\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02626\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cpg binding protein (protein containing phd finger and cxxc domain 1). [source:swissprot;acc:q9p0u4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activator of basal transcription 1; tata-binding protein-binding protein; basal transcriptional activator. [source:refseq;acc:nm\_013375]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytokine-like nuclear factor n-pac. [source:refseq;acc:nm\_032569]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hect type e3 ubiquitin ligase. [source:refseq;acc:nm\_015052]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.375\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.767\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02623\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
candidate tumor suppressor in ovarian cancer 2. [source:refseq;acc:nm\_080822]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.243\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02619\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer epsilon subunit (epsilon-coat protein) (epsilon-cop). [source:swissprot;acc:o14579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.849\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02599\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase 16 kda proteolipid subunit (ec 3.6.3.14). [source:swissprot;acc:p27449]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.186\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.672\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02593\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi complex associated protein 1; golgi resident protein gcp60; peripherial benzodiazepine receptor associated protein; golgi phosphoprotein 1; pbr associated protein; pka (rialpha)-associated protein. [source:refseq;acc:nm\_022735]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-sarcoglycan (sg-delta) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q92629]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular modulator of immune recognition. [source:refseq;acc:nm\_145021]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/